Radico FY26 Q1 update

Macro Economic Tailwinds of the Sector

• Rapid Economic Growth: India is one of the fastest growing economies with a rising middle class and the emergence of a sizeable high-income segment. These factors are transforming the overall consumption profile.
• Urbanization: Both urban and rural areas are witnessing increases in income, leading to a breakdown of the traditional urban-rural consumption divide.
• Favorable Demographics: A working-age majority and the rise of aspirational young millennials are driving demand for premium products.
• Technology & Innovation: India has an established technology backbone, fostering new business models and enhanced customer engagement.
• Changing Consumer Attitudes: Increased social acceptance of alcobev (alcoholic beverages) and a shift toward lifestyle-driven, premium consumption support sectoral growth.
• Global Positioning: India’s consumption growth outpaces major economies, positioning it to become the world’s third largest consumer market by 2026.
• Premiumization: There is a consistent trend towards premium and luxury spirits, underpinned by demographic changes and evolving consumer preferences.
• Low Per Capita Consumption: India’s IMFL (Indian Made Foreign Liquor) consumption per capita remains low (2.5 liters), indicating ample room for penetration and conversion from country liquor.

Growth Factors for the Company

• Strong & Growing Premium Portfolio: Continuous investment in developing and launching premium and luxury brands aligned with consumer aspirations.
• Successful Luxury Launches: Recent years have seen successful launches in luxury single malt, craft gin, and super-premium categories.
• Manufacturing Strength: Extensive manufacturing capacity (321mn liters, 43 bottling units), providing scale advantage and cost efficiencies.
• Pan-India Distribution: Robust sales through 100,000 retailers and over 10,000 on-premises outlets, ensuring strong availability and reach.
• Technology & R&D: Ongoing investment in technology-driven research and innovation.
• Exports: Operations have expanded to over 100 countries, building global equity and diversification.
• Efficient Supply Chain: Strategic locations lower operational and transport costs.
• Experienced Management: Board and senior management bring strong sectoral expertise, underpinning execution and innovation capabilities.

 Portfolio Composition

Segment	Key Brands & Market Status	Market Share / Position
Whisky	8PM, 8PM Premium Black, Royal Ranthambore, Rampur Single Malt, Spirit of Victory 1999 Pure Malt	5-80% depending on sub-segment
Vodka	Magic Moments, Magic Moments Verve, Magic Moments Dazzle	60%+ market share
Brandy	Morpheus, Morpheus Blue XO Brandy	60%+ market share
Rum	1965 Spirit of Victory, Contessa Rum	15-18% (CSD), leading positions
Gin	Jaisalmer Indian Craft Gin	50% share in luxury gin market

• Most new launches in the last 15 years have been in the premium segment, reinforcing the company’s premiumization strategy.
• The company’s brands feature prominently in The Millionaires’ Club global rankings, including Magic Moments (6th largest vodka worldwide) and Morpheus Brandy (top brandy and fastest-growing brandy).

Growth & Prospect of Prestige & Above (P&A) Segment

• Historic Growth: P&A segment volumes have grown at a CAGR of 13% since FY2019, with over 212% total volume growth in that period.
• Portfolio Focus: Resorting to successful premium and luxury product launches, including:
• Rampur Single Malt (various expressions, award-winning globally)
• Jaisalmer Indian Craft Gin (market leader in luxury gin, numerous awards)
• Spirit of Victory 1999 (expanding super-premium whisky segment)
• Magic Moments Verve, Dazzle Vodka, Morpheus Blue XO Brandy
• Revenue Contribution: In FY2025, Prestige & Above accounted for 46.1% of total IMFL volumes and 69.4% of total IMFL revenues.
• Financials: Realization per case for the P&A segment increased from ₹1,307 in FY2019 to ₹1,801 in FY2025.
• Volume Performance: Prestige & Above segment sold 13mn cases in FY2025 (up from 11.26mn in FY2024), contributing significantly to total own volumes.
• Strategic Outlook:
• Premiumization is expected to continue, supported by demographic trends and consumer preferences for quality.
• Fastest volume growth projected in white spirits (vodka, craft gin), with whisky and Indian single malt continuing to see premium demand.
• State policy focus on consumer experience and progressive excise changes favor up-trading to premium products.

Radico Khaitan continues to leverage macroeconomic, demographic, and consumer shifts to reinforce premiumization, scale, and brand value in both domestic and international markets, with the Prestige & Above segment positioned as the main engine for future growth.

24 March 2025 || Alcohol Industry || Radico Khaitan-part 2

Regulatory Reforms Driving Industry Growth

• Karnataka: The state has streamlined excise slabs, reducing the number of slabs from 18 to 16, simplifying pricing and reducing inter-state smuggling. This correction, particularly in the P&A segment, is expected to boost volume growth for Radico, which holds a 70/30 split of regular/P&A products.

• Andhra Pradesh: A key market (10% of industry volumes), transitioning from government-controlled distribution to private retail.

  • 3,736 liquor shops were auctioned in Oct 2024, enabling private retailers to sell IMFL (Indian-made foreign liquor) and boosting margins.

• Telangana: The government plans to clear dues owed to liquor companies by March 2025, restoring normal supply to the state beverage corporation and driving volume recovery.

• Gujarat: The traditionally dry state has allowed liquor to be served in GIFT City, opening up a new market for premium and luxury spirits.

Premiumisation Driving Growth

• Revenue Mix Shift:

  • The Prestige & Above (P&A) segment, which contributed 70% of sales in FY24, is expected to increase to 82% by FY27.

  • This is driven by consumer preference for luxury and semi-luxury brands, supported by improved distribution and product innovation.

• Luxury & Semi-Luxury Growth:

  • Recent premium launches like Royal Ranthambore Whisky, Jaisalmer Gold Gin, and Kohinoor Rum are boosting the luxury segment.

  • Expanded malt capacity will support the production of premium whisky brands, strengthening Radico’s presence in this high-margin category.

• Core Market Execution:

  • Radico is enhancing its go-to-market strategy in key regions like Uttar Pradesh, expanding into low-salience markets in South India.

  • Foray into new indigenous categories such as Mahua to diversify the product portfolio.

Financial Performance and Projections

• Revenue Growth:

  • 15% CAGR over FY24-27, driven by premiumisation and volume expansion.

  • The IMFL segment, contributing 70% of sales, is projected to grow at a 17% CAGR.

  • The non-IMFL segment (30% of sales) is expected to grow at 10% CAGR, with Uttar Pradesh Manufactured Liquor (UPML) leading the segment due to better realisations.

• Profitability:

  • EBITDA Margin: Expanding from 12.7% in FY24 to 16.5% in FY27, driven by premiumisation, backward integration, and cost-saving measures.

  • Net Profit: Expected to grow from INR 2,622 million in FY24 to INR 6,235 million in FY27, reflecting a 33% PAT CAGR.

  • EPS: Projected to reach INR 46.6 in FY27, up from INR 19.6 in FY24.

Cost Optimisation and Backward Integration

• Raw Material Costs:

  • ENA (Extra Neutral Alcohol) prices are expected to decline due to above-average monsoons and in-house ENA production from the Sitapur distillery, improving gross margins by 400 bps over FY24-27.

• Packaging Cost Savings:

  • Radico is shifting from glass bottles to PET bottles in the regular segment, reducing packaging costs.

  • Removal of mono cartons and introduction of low-unit packs (LUP) for premium brands will further enhance margins.

• Sitapur Distillery Expansion:

  • The 350 KLPD Sitapur distillery will double Radico’s total capacity to 213.3 million liters, improving cost efficiency through in-house production.

Product Portfolio and Expansion

• Vodka (Magic Moments):

  • Radico holds a 60%+ market share in the vodka segment, driven by premiumisation with brands like Magic Moments Dazzle.

  • Expansion into flavoured and cocktail vodkas with high-margin variants such as Gold and Silver editions.

• Whisky (8 PM):

  • The 8 PM Black label is driving premiumisation, with volumes expected to reach 4.5 million cases by FY27, up from 3 million cases in FY24.

  • Royal Ranthambore Whisky has seen 100% volume growth in FY24, with further scaling expected in FY25.

• Gin (Jaisalmer):

  • Expansion into luxury gin with the launch of Jaisalmer Gold edition (priced at a 50% premium to the base variant), catering to the fast-growing craft gin segment.

• Rum:

  • Launch of Kohinoor Reserve Indian Dark Rum, a luxury rum priced at around $50 per bottle, targeting global markets like the USA, UK, and EU.

Key Risks

• Regulatory Changes:

  • State-level policy changes, including potential tax hikes or tighter distribution regulations, could impact volumes and profitability.

• Raw Material Volatility:

  • Although ENA prices are expected to decline, unforeseen supply chain disruptions could increase costs.

• Competition:

  • Rising competition in the luxury and semi-luxury segments from new entrants and established players could limit Radico's market share gains.

Conclusion

Radico Khaitan is well-positioned for robust growth driven by premiumisation, backward integration, and cost optimisation measures. The double-digit revenue growth is backed by margin expansion, and the scaling of luxury and semi-luxury brands. The company's strategic focus on cost efficiencies, expanded distribution, and entry into new product categories makes it an attractive long-term investment.

12 March 2025 || Day 2/100 - Alcohol Industry || Allied Blenders

Financial Highlights

Revenue & EBITDA Growth: ABD is projected to achieve a 10% revenue CAGR and a 30% EBITDA CAGR over FY24-27E. This growth is largely driven by the expansion of the P&A segment, premiumization, and cost-saving initiatives.

• Profitability:

  • EBITDA margins are expected to expand from 7.3% in FY24 to 12.3% in FY27, driven by premium product launches, backward integration, and price hikes in key states.

  • Net profit is forecasted to surge from INR 67 million in FY24 to INR 2,623 million in FY27, reflecting robust operational efficiency and margin expansion.

• Revenue Split:

  • The P&A segment is expected to contribute 55% of total revenue by FY27, up from 47% in FY24, driven by higher realisations from premium brands.

  • The mass premium segment, led by Officer’s Choice, will see slower growth, stabilising at 45% of revenue by FY27.

Product Portfolio and Growth Strategy

• Premiumisation Trend: ABD is capitalising on the shift towards premium and luxury spirits with ICONiQ White Whisky and Sterling Reserve. ICONiQ has already achieved 2.3 million cases in FY24 and is expected to double volumes in FY25 as it expands into key markets like Karnataka and Andhra Pradesh.

• Backward Integration:

  • ABD has acquired a distillery in Maharashtra, expanding its ENA production capacity from 11 million litres p.a. to 63 million litres p.a. over three years, covering two-thirds of its ENA needs, which will improve cost efficiency.

  • A new malt maturation facility in Telangana will support the production of luxury products, while a PET bottle manufacturing plant with a capacity of 615 million bottles will reduce packaging costs.

• Cost-saving Measures:

  • ABD is driving cost efficiencies by gradually removing monocartons from packaging and introducing PET bottles, which are cheaper than glass.

  • The company has also launched tetrapacks for smaller Officer's Choice Whisky packaging in three states, aiming to expand this cost-effective format.

Market and Distribution

• Market Share: ABD is the third-largest IMFL company in India by sales volume, with an 8.2% market share in FY23. The company sold 31.7 million cases in FY24, maintaining a strong foothold in the industry.

• Extensive Distribution Network:

  • ABD has a pan-India distribution network spanning 79,000+ retail outlets across 30 states and UTs. This vast reach gives it a competitive advantage in a highly regulated industry where entry barriers are high.

  • The company also exports to 14 international markets, boosting its global presence.

• Strategic Partnerships:

  • ABD has partnered with Roust Corporation to distribute Russian Standard Vodka in India. This premium vodka, priced between INR 2,200 and INR 5,000, will enhance ABD’s presence in the growing vodka market.

  • The company has also entered into a strategic partnership with Bollywood actor Ranveer Singh to promote its premium and luxury spirits, with ABD holding an 80% equity stake in the venture.

Key Risks

• Regulatory Uncertainty: State-specific policies could significantly impact ABD’s growth. A potential ban on spirits in key states or increased taxation could reduce sales and profitability.

• Raw Material Price Volatility: ABD is highly exposed to fluctuations in ENA and glass prices, which make up two-thirds of its raw material costs. Price hikes in these commodities could pressure margins.

• Consumer Preferences: Shifts in alcohol consumption trends or the rising popularity of craft and niche spirits could reduce the demand for ABD’s mass premium products.

Overall Conclusion

ABD is positioned for strong growth driven by premiumization, backward integration, and cost-saving initiatives. The upside potential, supported by double-digit revenue growth, margin expansion, and new product launches in premium and luxury segments. With a robust distribution network and strategic partnerships, ABD is expected to sustain its market leadership and enhance profitability over the next few years.

11 March 2025 || Day 1/100 - Healthcare Industry

I have decided to move forward with only 2 sectors Healthcare and Alco Bev as it wasn't very practical to track 3 sectors at the same time. 

In this blog i talk about how to evaluate healthcare sector. Here we will understand about how the hospitals model work, Comparing KPIs used to evaluate stocks across the spectrum and finally valuation multiples to evaluate the company. 

Low cyclicality business - Demand in hospitals business is rarely affected by the market conditions because economic conditions have nothing to do with people getting sick, as it was witnessed that even during periods of recession where revenues remained constant with minute adverse effect in Margins.

Capital requirements - To establish a hospital huge sums of capital is required to invest in land, building, Highly specialized Doctors, Intricate Medical equipments, high working requirements to keep the hospital up and running. Investing in substantial amount of capital means investing for long term which requires long term commitment from the promoters to even bear losses in initial years as hospitals have a big gestation periods.

Economies of scale - Hospitals are generally 

Mature Hospitals

Insurance Coverage

Regulatory Risk

Occupancy Rate

ARPOB

Avg length of stay

Payor Mix

Revenue Growth

Earnings growth

EBITDA Margin

Capex

EV/EBITDA

10 March 2025 || Day 0/100

 I have decided to pick 3 sectors. 

I am questioning myself why? why not just 1? that is what has been suggested by everyone

because 1 i am familiar with but not an expert in is alcobev sector and it won't do any addition if i just pick that sector. 

Ok then why not 2? you'll have an easy hand on alcobev but also a new sector to learn.

Yes good point, but i recently started reading on healthcare sector and i can't get away from my fascination of this sector as the sector is evolving at a rapid pace with AI integration and the substantial amount of PE deals happening in the sector. which is the ultimate place i want to be.

Understood. Then you should just stick with these 2 sectors. why put one more ball in your basket?

Because most IB analyst positions or equity research positions under my sight are looking specifically for Real estate sector specifically.

Ohh so you just wanna learn about real estate because it might land you a job opportunity.

Pretty much yes but one more thing, I have never been able to figure out this sector like what do companies in real estate do? are they just construction companies or are they just real estate selling companies via tender. Actually this question was partially answered by my friend recently who has 3 years of workex in real estate. It includes the rebars/re-inforcing bars and other construction materials too, i mean that is what i remember.

Maybe you don't remember it correctly.

Possible but i still wanna pick 3 sectors as this is the number which popped in my head as soon as i thought of picking the number of sectors to track. and also i do have a little time on my side, I'll just have to restrict fun for a while, which is ok considering that i am doing this for my future self.

Sure if you are ok going into this then go for it.

It is Final then, I am picking Alcobev industry, Heathcare industry and Real estate industry.

And the players i'll be focusing are 

Alcobev - United Spirits || Radico Khaitan || Allied Blenders

Healthcare - Max Healthcare || Apollo Hospitals || Dr. Lal pathlabs

Real estate - DLF || Macrotech Developers || Oberoi Realty

All set! 

Indus Valley Annual Report 2025 - Interpretation

Background about the authors:-

Sajith Pai - linkedin.com/in/sajithpai

Anurag Pagaria - linkedin.com/in/anuragpagaria

Nachammai Savithiri - linkedin.com/in/nachammai-savithiri

Blume is an early stage venture fund that backs startups with both funding as well as active mentoring. Blume has a great investing track record with investments worth ₹114 crores in 78 companies which have resulted in a gross total returns of ₹651 crores from just 17 companies.

This "Indus Valley report" is their annual publication that offers in-depth analysis of Indian startup and venture ecosystem.

This post is going to flow like the report but with a little twist. As the report is only consisted of Charts and graphs, I will pick and try to deep dive in each of the variables involved in graph and what has been the history for that data, How does it affect indian economy, What were the prospective results of the data in other countries who have already experienced current stage of Indian economy, And if possible will also try to identify the industry expected to be affected due to trends identified in this report as the Indian economy is at an inflection point currently.

India vs the World: Where India stands, today

1. Real GDP Growth (in%)

Real GDP shows actual growth by using current period prices for GDP computation, thereby eliminating the misjudged inflation growth as real growth.

Looking at Growth rate in isolation leads to a false picture that India is going to beat other countries in coming decades as we have benefit of demographic dividend coupled with high growth rate. If we look at absolute number in GDP growth rate it shows that it isn't that great a picture as we stand on a very low base to grow at 6.5% growth rate to compete with other countries because even if other countries like China and USA grow at lower rates they will be growing larger. It has been demonstrated below.

India does have a demographic dividend advantage, but it has not been able to reap its benefits yet as other countries did in their growth period/decades. As demonstrated below when earlier economies for example China was enjoying benefits of demographic dividend it had growth rate in double digits and here India even after 5 years of entering its expected golden years can't grow at more than 8%.

Hence, Concluding that having 6.5% growth rate is not a beneficial factor when looked with a broader perspective.

2. Per Capita

Understanding Indian Rupee ₹

For a basic and simple understanding base currency can be assumed as a commodity which is to be purchased by paying price currency. 

Types of exchange rates

 - Fixed Exchange rate - Rate is pegged by selling or buying foreign exchange by the central bank. Helps in standardization of exports and stabilization of inflation rate. Biggest hinderance is that to maintain fixed rate central bank needs to have huge reserves. Ex. SAR (Saudi Rial)

 - Floating Exchange rate - Rate is set to be decided by the market forces and no intervention by central bank to alter the rate. Ex. JPY  

 - Managed floating rate - Determined by market forces but altercation to keep inflation and trade deficit stable actions are taken by central bank occasionally. Helps to keep competitiveness in trade. Ex. INR

No exchange rate is perfect. Each country evaluates multiple factors like whether the country's economy is an industry driven economy or a service based economy, whether trade is in deficit or surplus consistently, is it a developing economy or a developed economy and then adopt a suitable rate.

Principle of Financial trinity - Also known as the impossible trinity or unholy trinity or monetary trilemma explains that a country cannot simultaneously achieve its 3 major goals which are - Free Capital Mobility, Fixed Exchange rate and Independent monetary policy.

To explain this principle there is an elaborate example

Assume that world interest rate is at 5%. If the home central bank tries to set domestic interest rate at a rate lower than 5%, for example at 2%, there will be a depreciation pressure on the home currency, because investors would want to sell their low yielding domestic currency and buy higher yielding foreign currency. If the central bank also wants to have free capital flows, the only way the central bank could prevent depreciation of the home currency is to sell its foreign currency reserves. Since foreign currency reserves of a central bank are limited, once the reserves are depleted, the domestic currency will depreciate.

Hence, all three of the policy objectives mentioned above cannot be pursued simultaneously. A central bank has to forgo one of the three objectives.

If 1$ from Rs. 80 moves to Rs. 85. $ is appreciated and Rs. is depreciated

If in the above example rupee is appreciated it will attract FPIs due to INR strengthening amplifying the returns when converted to INR from Dollar. It reduced inflation and negative impact on Indian export industry as the Indian goods become expensive in the international markets.

On the other hand, during Rupee depreciation exports will be pushed as the Indian goods become cheap for global buyers. It increases potential for FDI in the country as this situation is best suited for long term investments. Inflation is also expected to see a rise. Imports will effect Indian trade deficit adversely.

If inflation differential dominates, currency will depreciate faster as high inflation erodes the currency value. If capital flow of currency is higher than inflation differential then currency will appreciate due to increased foreign investments.

History of Rupee devaluation

1947-1966 - After independence Rupee was pegged to British pound until 1966, which held up $/INR rate to ₹4.67/$

1966-67 was a bad year for Indian economy as due to severe balance of payment crisis we had to devalue the rupee by 37% from ₹4.67/$ to ₹7.5/$. Slow economic growth and high reliance on imports led to persistent trade deficit situation.

1970-1980 - US invented the Bretton woods system and $ became a floating currency which was no longer hedged to gold or any commodity. India pegged INR to basket of currencies including dollar. The price of oil quadrupled from $3.00 to $12.00 per barrel due to the Arab-Israeli conflict of 1973,which further increased to $36.83 per barrel in 1979–1980 due to the Iranian revolution and the Iran-Iraq war. The oil price shocks increased India's import bill further weakening the rupee. During mid of 1981 ₹ touched near 9/$.

1981-1990- India relied heavily on external borrowings to finance its growth fiscal and trade deficit. Rupee steadily depreciated to ₹17/$ within the next 9 years on March 13, 1990.

1991-2000 - In 1991, India again faced severe balance of payment crisis, with forex reserves depleting to just 2 weeks worth of imports. Government was forced to adopt liberalization due to IMF and world bank pressures. Major factor which contributed to decline in rupee value were persistent trade deficit, rising inflation and capital account liberalization which led to forex rate volatility. Rupee devaluated from ₹17/$ to ₹40/$ at the start of early 2000.

2001-2007 - A good period for Rupee as it had started signaling appreciation. Liberalization scheme worked for India as with huge inflows of dollar in country investors preferred India and inflation also was low during this period.

2008 - Global crisis hit the world economy and crude oil prices went through the roof to $150/ barrel in march 2008. Due to rising crude oil prices $ forex reserves went out of developing economies and rupee started depreciating again.

2009-2020 - After 2008 inflation in India skyrocketed to double digits and thereon high inflation and trade deficits never gave Rupee a chance to recover and INR depreciated to ₹75/$ by early 2020.

After 2020 - Rupee has continued to depreciate at its historical average of 3% every year and recently made new lows of  ₹ 87.986/$ on Feb 10, 2025.

Checklist while reading an annual report

Section - Que to asked / Info to be sought


Auditor's Report

Has any auditor given a qualification to the company in last 3-5 years?
Has the auditor resigned in the last 3 years?
What does the auditor says about the internal financial controls?
What's the qualification ?
What's his remuneration?
Does the auditor have a genuine website & Linkedln profile?
What's the revenue growth vis a vis the auditor's remuneration growth?
What are the key audit matters(KAM) in the business?
What's his view on the accounting policies Of the business?
Any red flag or doubt he has pointed out?


Business Model

How does the company make money?
What type of products/services are these?
How is the revenue recognized?
Is the company's products or services discretionary or what? 

What's the type of industry a company is in?
What about the competitive intensity?
How's the volume growth if a manufacturing business?


Corporate Governance

Understand all the related party transactions!
What is the auditor saying about the transactions?
How much the growth in salary of staff?
What's the median salary of employees to chairman's?
How is the auditor behaving?
Has the CFO, CEO & Independent directors resigned in last year?
How's the auditor's report! – Opinion?
Who is the auditor?

Management discussion and Analysis

 
What's the management saying about the business performance.
What guidance are they giving for the future?
What's their view on the industry?
Understand the reason behind the revenue growth or degrowth!
Look for the margin guidance as well
What are the capex plans
What happened with the previous capex plans?
What do they say about the competition?
How the industry & company Will evolve in coming times?

Notes to Accounts

Which depreciation method is being used?
What type of accounting policies are being applied?
Are accounting policies being changed over & over again?
Look at the different schedules & their duration!
Has company written off any asset or intangibles?

Resources for research

Screener

For majorly sourcing the company's historical financial data, concalls, credit rating reports and annual reports

https://www.screener.in/

Investing

Similar to screener but a little diverse database in a different setting

https://www.investing.com/

Trading Economics

To get a global database for broader comparison

https://tradingeconomics.com/

Yahoo Finance

T bond rates and commodities prices with some historical price data

https://finance.yahoo.com/

Prime Investor

Market returns over a period of time along with dividend yield

https://primeinvestor.in/

Trendlyne

Research reports and Key metrices

https://trendlyne.com/features/

Factset

Ebook and articles on multiple industries

https://www.factset.com/

Annual Report

The starting point for any research. Don’t just skim the financials—read up on the management’s vision and the company’s direction. It’s the company’s story in one place.

Analyst Briefings & Investor Presentations

Think of these as the company’s “highlights reel.” They often summarize key metrics and operational details that may be buried in the annual report.

Credit Reports

S&P, Moody’s, and CRISIL reports focus on the company’s creditworthiness. They dive deep into liquidity, credit, and financial stability. Definitely worth a read.

Equity Research Reports

Brokers and investment firms release these with detailed projections, valuations, and potential risks. If you’re looking for growth forecasts and insights, these are invaluable.

Industry Reports

Companies operate within a broader industry. Look at industry reports (global and regional) to understand market trends and see how the company compares to competitors.

Overview of the Indian Healthcare sector Transformation

 

The Indian healthcare sector is undergoing a profound transformation driven by increased government funding, rapid advancements in digital health technologies, and the strategic integration of artificial intelligence (AI). This comprehensive guide provides an in-depth overview of the sector, detailing crucial aspects such as budget allocations, market growth projections, technological adoption trends, and major government initiatives. Enhanced healthcare spending, digital advancements like the Ayushman Bharat Health Account (ABHA) with 568 million accounts created as of March 2024, and AI integration in medical imaging and rural healthcare are pivotal in enhancing service delivery. Major government initiatives, including the development of medical device parks and the establishment of AI Centres of Excellence, are set to further revolutionize the sector. However, challenges such as infrastructure gaps, financial constraints, and limited digital literacy remain.

Healthcare Budget for Fiscal Year 2025-26

Budget Allocation Overview

The Indian government has demonstrated strong commitment to enhancing healthcare infrastructure and services with substantial budget allocations:

- National Health Mission (NHM) Budget: INR 37,226.37 crores

- Total Department of Health and Family Welfare Budget: INR 95,957.87 crores

These allocations mark a significant increase from previous years and reflect a robust dedication to strengthening health infrastructure, improving medical education, and advancing digital health initiatives nationwide.

Factors Contributing to Increased Budget

Several key factors have driven the significant increase in the healthcare budget for FY2025-26:

- COVID-19 Pandemic Aftermath: The pandemic's ongoing impact necessitated increased funding for bolstering healthcare infrastructure and preparedness.

- Healthcare Access Expansion: Substantial investment required to expand healthcare access in rural and underserved areas.

- Technological Advancements: Prioritization of investments in digital health technologies, including telemedicine and AI-based diagnostics.

- Public Health Initiatives: Enhanced focus on vaccination drives, disease prevention campaigns, and other public health programs.

- Policy Reforms: Government measures aimed at improving healthcare delivery and infrastructure efficiency.

Historical Budget Progression

The growth trajectory of the healthcare budget is as follows:

- 2022-23 (actual): INR 83,000 crores

- 2023-24 (actual): INR 86,175 crores

- 2024-25 (current): INR 87,656.90 crores

- 2025-26 (projected): INR 95,957.87 crores

This steady increase underscores a long-term commitment by the government to upgrade the healthcare sector.

National Health Mission (NHM) Allocation Comparison

Expenditure within the NHM has increased consistently:

- 2022-23 (actual): INR 33,402 crores

- 2023-24 (actual): INR 34,652 crores

- 2024-25 (current): INR 35,945 crores

- 2025-26 (projected): INR 37,226.37 crores

Key expenditure areas under the NHM include maternal and child health, communicable disease control, and health system strengthening.

Advancements in Infrastructure and Education (FY2023-25)

The increased budget has catalyzed important improvements:

- Infrastructure Development: Expansion of healthcare facilities, construction of new hospitals, and modernization of existing infrastructures.

- Medical Education: Establishment of new medical colleges, enhancement in post-graduate education, and integration of advanced technologies in training.

- Digital Health: Significant resources dedicated to telemedicine, electronic health records, and AI-driven healthcare solutions.

Alignment with Sector Needs and Public Health Outcomes

Budget allocations are aligned with:

- Primary Healthcare: Strengthening primary care centers.

- Specialized Care: Enhancing tertiary and specialized medical institutions.

- Public Health: Funding preventive healthcare and public health programs.

Quantitative metrics evaluating these impacts include Infant Mortality Rate (IMR), Maternal Mortality Rate (MMR), life expectancy, and the Healthcare Access Index. International comparisons indicate that while India's spending remains relatively low compared to similar economies, recent increases are bridging this gap.

Digital Health Initiatives

An important portion of the healthcare budget is dedicated to digital health, focusing on:

- Telemedicine Expansion: Increasing access to remote consultations.

- AI-Driven Diagnostics: Implementing AI for early disease detection and diagnosis.

- Health Identity Cards: Providing digital health identity cards for gig workers and integrating with the e-Shram portal.

These investments aim to modernize the system and improve the efficiency of healthcare service delivery.

Growth of the Indian Healthcare Market

Medical Value Travel (MVT)

India has emerged as a preferred destination for medical tourism due to high-quality healthcare at competitive prices:

- Estimated Market Size: US$ 5-6 billion

- Number of International Patients Annually: Approximately 500,000

- Key Drivers: Competitive treatment costs, advanced medical technology, skilled healthcare professionals, and shorter waiting times.

E-health Market

The digital health sector is experiencing rapid growth:

- Projected Market Size by 2025: US$ 10.6 billion

- Key Factors: Increasing smartphone penetration, government support, telemedicine adoption, and rising demand for remote healthcare services.

Overall Market Projections

- 2025 (Forecast): USD 8.71 billion

- 2030 (Forecast): USD 16.21 billion

- Compound Annual Growth Rate (CAGR): 13.23% (2025-2030)

Digital Health Market Projections

- Market Size 2025: USD 6.33 billion

- CAGR (2025-2029): 11.83%

- Projected Market Value by 2029: USD 9.90 billion

- Average Revenue Per User (ARPU): USD 45.22

These figures illustrate India’s growing potential as a global hub for medical tourism and digital health.

AI Integration in Indian Healthcare

Artificial intelligence is revolutionizing healthcare delivery by enhancing diagnostics, treatment protocols, and overall patient care.

Administrative and Operational Efficiency - AI improves administrative tasks such as appointment scheduling, patient triaging, and record-keeping. Its application has reduced healthcare worker errors by 86% and decreased patient wait times by 30%.

Telemedicine and Rural Healthcare - AI-powered telemedicine platforms are bridging the urban-rural divide. During the pandemic, telemedicine services witnessed high acceptance, with adoption rates in rural areas at 88%, semi-urban areas at 84%, and urban areas at 83.4%.

Early Disease Detection - AI systems facilitate early disease detection in primary health centers and government hospitals, particularly for conditions such as cancer and tuberculosis. This early detection has enabled timely interventions and improved patient outcomes.

Wearable Devices and Diagnostics - AI-equipped wearable devices enable real-time health monitoring, providing vital data for preventive care and chronic disease management. The global wearable AI market is projected to reach $138.5 billion by 2029 with a CAGR of 17.2%.

Addressing Workforce Shortages - By enhancing clinical decision-making, AI assists healthcare workers in focusing on complex tasks, partially mitigating workforce shortages. Its implementation has reduced operational costs by 70% and improved drug discovery processes.

Public Health and Socio-Economic Context - AI applications in population health management are being developed to address broader public health challenges and socio-economic determinants of health. Efforts to integrate AI with existing healthcare schemes are ongoing.

Ethical and Legal Considerations - The sector is actively addressing ethical and legal challenges connected to AI adoption, including data privacy, algorithmic bias, and regulatory compliance. The Digital Personal Data Protection (DPDP) Rules implemented in 2025 focus on data privacy and AI deployment, providing mechanisms for data access rights, consent withdrawal, and complaint handling.

Healthcare Infrastructure Technology in India

Telemedicine

Telemedicine has seen widespread adoption, significantly accelerated by the COVID-19 pandemic:

- Adoption for Physical Health: Increased from 22% (as of August 2022) to 42% (as of February 2025)

- Adoption for Mental Health: Rose from 33% (as of August 2022) to 47% (as of February 2025)

Factors driving this surge include improved internet connectivity, increased awareness, and the benefits of telemedicine, particularly in rural and underserved areas.

Electronic Health Records (EHRs)

Government initiatives to promote EHR adoption are creating a more integrated healthcare system. These efforts have improved continuity of care, data management, and overall operational efficiency in healthcare facilities.

AI in Diagnostics

AI is increasingly used in diagnostics, particularly in radiology, pathology, and oncology. Its application has led to a 20% increase in early disease detection rates and achieved 90% accuracy in predictive diagnostics.

Government Programs and Policies

- National Digital Health Mission (NDHM): Aims to establish a comprehensive digital health ecosystem that includes a digital health ID system.

- Ayushman Bharat Digital Mission (ABDM): Strengthens integrated digital health infrastructure across India. By June 2023, ABDM registered over 400 million beneficiaries, linked 273 million health records, and verified 190,000 healthcare professionals alongside 208,000 health facilities.

Challenges in Technology Adoption

Despite rapid progress, challenges remain:

- Infrastructure issues such as inadequate bed-to-patient ratios and insufficient technological facilities, especially in rural regions.

- Data privacy concerns addressed through the Digital Personal Data Protection Act 2023, which mandates explicit consent for processing sensitive personal data.

- Training and capacity-building programs are underway to help healthcare professionals adapt to new technologies.

India's Digital Healthcare Transformation

Ayushman Bharat Digital Mission (ABDM)

The ABDM is a flagship initiative aimed at creating a national digital health ecosystem with significant progress:

- Key Progress Metrics (as of September 2024):

   - Health Facilities: 131 healthcare facilities selected based on their registration on the Health Facility Registry (HFR) and implementation of ABDM-enabled software.

   - ABHA (Health IDs): Over 67 crore Ayushman Bharat Health Accounts created.

   Latest Statistics (as of December 2024):

   - Total ABHA Created: 71.16 crore, with Uttar Pradesh leading at approximately 81 million accounts.

   - Registered Health Facilities: 3.54 lakh facilities, with the top 5 states controlling over 60% of empanelled facilities under PMJAY.

Key Implementation Components

- Federated Health Records Exchange System: Ensures data interoperability and security, with 70% of hospitals engaged in all four domains of exchange and access to over 7.9 million records.

- Digital Health IDs for Citizens: Despite challenges such as security, privacy, and infrastructure issues, enhanced cybersecurity measures and standardization efforts are in place.

- Focus on Universal Health Coverage: Emphasizing efficiency, accessibility, inclusiveness, and affordability.

- Agile Implementation Approach: Following the "Think big, start small, scale fast" philosophy with a federated architecture and a five-layered system of building blocks.

- Governance: The National Health Authority (NHA) oversees design, registry creation, standard setting, data privacy, and policy governance for effective compliance across states and regions.

Market Growth Potential and Challenges

- Market Growth Potential: Digital healthcare is forecasted to expand from $2.7 billion in 2022 to an estimated $37 billion by 2030. This growth is driven by rising internet and smartphone penetration, expanding telehealth services, a robust foundation of government initiatives, increasing demand for remote patient monitoring, and significant investments in healthcare technology startups.

- Challenges: Include legal and regulatory hurdles balancing innovation with data protection, confidentiality, and security vulnerabilities in data transmission, along with infrastructure limitations in rural areas due to inadequate internet connectivity, limited technical infrastructure, and high installation and operational costs.

Conclusion

The Indian healthcare sector is poised for substantial growth and transformation driven by the rapid adoption of digital health services, sizeable budget allocations, and significant advances in AI and technology. The Ayushman Bharat Digital Mission is reshaping the landscape, making healthcare more accessible, efficient, and inclusive. 

Key takeaways include:

1. Robust government support through increasing budget allocations and groundbreaking initiatives.

2. Rapid growth in digital health and telemedicine adoption, evidenced by over 1.3 billion digital health service users and 71.52 crore ABHA IDs created by December 2024.

3. Significant opportunities for innovation in AI across many healthcare domains, with projections for the AI healthcare market to reach $1.6 billion by 2025.

4. Critical challenges such as infrastructure development and data management highlight areas for further innovation and investment, including addressing security and regional disparities.

5. A focused effort on improving healthcare accessibility and quality, particularly in rural and underserved regions, with planned expansions in hospital beds and medical professional availability.

As the sector evolves, the opportunities for innovation, investment, and impactful contributions to healthcare outcomes continue to expand, setting a benchmark for comprehensive digital health transformation.

Radico Khaitan Investment Thesis

 Radico Khaitan is one of India’s leading manufacturers of alcoholic beverages, with a strong portfolio of premium brands. Here's are key drivers that support its growth story:

1. Strong Brand Portfolio & Premiumization Trend

• Premiumization of Products: Radico Khaitan has increasingly shifted towards higher-margin, premium spirits like Rampur Indian Single Malt and Royal Ranthambhore brands. As Indian consumers continue to move towards premiumization in alcohol consumption, Radico is well-positioned to benefit from this shift.
• Brand Recognition: With established brands such as Magic Moments Vodka, Rampur, and Morani, the company has a solid brand equity that resonates with a broad consumer base.

2. Revenue and Profitability Growth

• Steady Revenue Growth: Radico Khaitan has demonstrated consistent growth in both top-line and bottom-line performance. The company has delivered robust financial results, driven by both volume growth and premium product adoption.
• Strong Operating Margins: The shift toward higher-margin products (premium brands) and cost control measures has helped improve profitability, leading to healthy operating margins.
• Diversified Revenue Streams: Radico's portfolio spans multiple categories of alcoholic beverages, ensuring diversified revenue streams. This reduces the company's reliance on any single product segment and mitigates risks.

3. Expanding Market Presence

• Geographic Expansion: Radico is expanding its footprint both within India and internationally, capitalizing on the rising demand for Indian-made foreign liquor (IMFL) in global markets. Their push into international markets such as Europe, the Middle East, and the US is a key growth driver.
• Domestic Growth: India’s alcoholic beverage market is growing rapidly, particularly with increased acceptance of premium brands. Radico’s expanding distribution network across smaller cities and towns ensures it taps into the evolving demand from rural and semi-urban areas.

4. Favorable Industry Tailwinds

• India's Alcoholic Beverage Market: The alcoholic beverage industry in India is growing due to increased disposable incomes, a growing young population, and changing social habits. Radico, with its focus on premium products, stands to benefit from the expanding premium market.
• Government Policies: Although the alcohol industry is heavily regulated, favorable government policies (such as excise duty reductions) in select regions could lead to higher margins for Radico.

5. Sustainable Practices and Corporate Governance

• Sustainability Initiatives: The company’s commitment to sustainability, with steps like water conservation and eco-friendly production practices, aligns with modern consumer values and can be a key differentiator in the long term.
• Strong Corporate Governance: Radico Khaitan has a track record of good corporate governance and transparency, which is essential in maintaining investor confidence and attracting long-term capital.

6. Valuation

• Attractive Valuation: Compared to its industry peers, Radico Khaitan's valuations may present an attractive entry point, especially given its growth trajectory in the premium segment. When factoring in its consistent earnings growth, strong brand equity, and market expansion plans, the stock may appear undervalued.
• Upside Potential: Despite the market's focus on short-term risks, the long-term growth prospects in premium alcohol, international markets, and broader consumption trends provide a compelling case for the stock's upside potential.

7. Resilient Performance in Economic Cycles

• Defensive Nature of Alcohol: Alcohol consumption tends to be less sensitive to economic cycles compared to other discretionary goods. This makes Radico Khaitan a relatively defensive investment, providing stability during periods of economic downturns.

Conclusion:

Radico Khaitan's robust brand portfolio, strategic shift towards premiumization, and expansion into new markets, combined with the growth potential in the Indian alcohol market, provide a strong investment case. The company is well-positioned to capture long-term growth, especially as the premium alcohol segment continues to expand.